Outlook on the Worldwide Coronary Artery Bypass Grafts Industry to 2025 - Featuring Abbott, Boston Scientific & Edwards Lifesciences Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Coronary Artery Bypass Grafts (CABG) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis and the looming economic recession, the Coronary Artery Bypass Grafts (CABG) market worldwide will grow by a projected US$46.1, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 5%.

On-Pump or Traditional Coronary Artery Bypass Grafting, one of the segments analyzed and sized in this study, is forecast to grow at over 4.7% and reach a market size of US$62.7 by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The On-Pump or Traditional Coronary Artery Bypass Grafting market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 5.9% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$2.8 to the region's size over the next 7 to 8 years. In addition, over US$1.4 worth of projected demand in the region will come from Rest of European markets. In Japan, the On-Pump or Traditional Coronary Artery Bypass Grafting segment will reach a market size of US$5 by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Coronary Artery Bypass Grafts (CABG) market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 4.9% over the next couple of years and add approximately US$7.3 in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Coronary Artery Bypass Grafts (CABG) market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Abbott Laboratories, Inc.; Boston Scientific Corporation; Edwards Lifesciences Corporation; Genesee BioMedical, Inc.; Hancock Jaffe Laboratories, Inc.; HeartWare International, Inc.; Karl Storz GmbH & Co. KG; Maquet Holding B.V. & Co. KG; Medtronic PLC; Novadaq Technologies, Inc.; TandemLife

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Coronary Artery Bypass Grafts (CABG) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession
  

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/8zdrzz

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.